Alkem Laboratories Limited (NSE:ALKEM) — Market Cap & Net Worth
Market Cap & Net Worth: Alkem Laboratories Limited (ALKEM)
Alkem Laboratories Limited (NSE:ALKEM) has a market capitalization of $6.92 Billion (Rs639.43 Billion) as of June 17, 2026. Listed on the NSE stock exchange, this India-based company holds position #2940 globally and #129 in its home market, demonstrating a -0.16% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alkem Laboratories Limited's stock price Rs5348.00 by its total outstanding shares 119565000 (119.56 Million). Review ALKEM total liabilities to assess the company's total debt and financial obligations.
Alkem Laboratories Limited Market Cap History: 2015 to 2026
Alkem Laboratories Limited's market capitalization history from 2015 to 2026. Data shows growth from $1.78 Billion to $6.92 Billion (14.59% CAGR).
Index Memberships
Alkem Laboratories Limited is a constituent of 10 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY PHARMA
CNXPHARMA
|
$91.62 Billion | 7.55% | #7 of 20 |
|
NIFTY MIDCAP 100
NIFMDCP100
|
$529.74 Billion | 1.31% | #38 of 100 |
|
NIFTY100 EQUAL WEIGHT
NIFTY100EW
|
$1.76 Trillion | 0.39% | #62 of 99 |
|
NIFTY 200
NIFTY200
|
$2.55 Trillion | 0.27% | #112 of 200 |
|
NIFTY 500
NIFTY500
|
$3.11 Trillion | 0.22% | #120 of 500 |
|
NIFTY HEALTHCARE
NIFTYHEALTHCARE
|
$110.04 Billion | 6.28% | #9 of 20 |
|
NIFTY MIDCAP 150
NIFTYMIDCAP150
|
$710.08 Billion | 0.97% | #42 of 150 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.14 Trillion | 0.61% | #52 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.20 Trillion | 0.22% | #119 of 750 |
|
NIFTY MIDCAP 50
NIMDCP50
|
$303.06 Billion | 2.28% | #24 of 50 |
Weight: Alkem Laboratories Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Alkem Laboratories Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Alkem Laboratories Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
Alkem Laboratories Limited's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.33x
Alkem Laboratories Limited's market cap is 0.33 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.98 Billion | $48.65 Billion | $7.42 Billion | 0.04x | 0.27x |
| 2017 | $2.68 Billion | $56.16 Billion | $8.92 Billion | 0.05x | 0.30x |
| 2018 | $2.39 Billion | $63.04 Billion | $6.31 Billion | 0.04x | 0.38x |
| 2019 | $2.49 Billion | $72.66 Billion | $7.61 Billion | 0.03x | 0.33x |
| 2020 | $3.66 Billion | $81.92 Billion | $11.27 Billion | 0.04x | 0.32x |
| 2021 | $4.57 Billion | $87.28 Billion | $15.85 Billion | 0.05x | 0.29x |
| 2022 | $3.83 Billion | $105.12 Billion | $16.46 Billion | 0.04x | 0.23x |
| 2023 | $6.68 Billion | $114.40 Billion | $9.84 Billion | 0.06x | 0.68x |
| 2024 | $7.28 Billion | $124.39 Billion | $17.96 Billion | 0.06x | 0.41x |
| 2025 | $7.12 Billion | $128.05 Billion | $21.65 Billion | 0.06x | 0.33x |
Competitor Companies of ALKEM by Market Capitalization
Companies near Alkem Laboratories Limited in the global market cap rankings as of June 17, 2026.
Key companies related to Alkem Laboratories Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #561 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #624 globally with a market cap of $44.20 Billion USD ( CN¥302.05 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #561 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.22 |
| #624 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.20 Billion | CN¥47.35 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
Alkem Laboratories Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Alkem Laboratories Limited's market cap moved from $1.78 Billion to $ 6.92 Billion, with a yearly change of 14.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs6.92 Billion | -2.88% |
| 2025 | Rs7.12 Billion | -2.26% |
| 2024 | Rs7.28 Billion | +9.11% |
| 2023 | Rs6.68 Billion | +74.36% |
| 2022 | Rs3.83 Billion | -16.27% |
| 2021 | Rs4.57 Billion | +25.11% |
| 2020 | Rs3.66 Billion | +46.67% |
| 2019 | Rs2.49 Billion | +4.25% |
| 2018 | Rs2.39 Billion | -10.93% |
| 2017 | Rs2.68 Billion | +35.89% |
| 2016 | Rs1.98 Billion | +10.84% |
| 2015 | Rs1.78 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Alkem Laboratories Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.92 Billion USD |
| MoneyControl | $6.92 Billion USD |
| MarketWatch | $6.92 Billion USD |
| marketcap.company | $6.92 Billion USD |
| Reuters | $6.92 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Alkem Laboratories Limited
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective… Read more